Section Arrow
ZBH.NYSE
- Zimmer Biomet Holdings
Quotes are at least 15-min delayed:2025/04/29 23:19 EDT
Last
 102.79
+1.03 (+1.01%)
Day High 
103.28 
Prev. Close
101.76 
1-M High
114.44 
Volume 
925.70K 
Bid
100
Ask
103.44
Day Low
101.1 
Open
101.63 
1-M Low
93.1 
Market Cap 
20.13B 
Currency USD 
P/E 22.97 
%Yield 0.93 
10-SMA 99.19 
20-SMA 103.28 
50-SMA 105.81 
52-W High 123.96 
52-W Low 93.1 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
4.43/8.89
Enterprise Value
25.47B
Balance Sheet
Book Value Per Share
63.02
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
7.68B
Operating Revenue Per Share
36.79
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed:2025/04/29 23:19 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.